Keratinocyte Transfection Kit
| Kit size Volume | Quantity | ||
|---|---|---|---|
| 0.5 ml(Cat-178374) | Inquiry | Add to cart | |
| 1.5 ml(Cat-178475) | Inquiry | Add to cart | |
| 1.5 ml CRISPR(Cat-216476) | Inquiry | Add to cart | |
| 8.0 ml(Cat-705377) | Inquiry | Add to cart |
Description
Product Information
Modes of administration
Reagent exhibits at least 85% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Description
Keratinocytes, the predominant cell type in the epidermis, have been demonstrated to be useful in developing in vitro techniques to assess skin irritants. Additionally, these cells are the principal source of the proinflammatory cytokine IL-1 in the epidermis, highlighting their role in the regulation of the immune response. Investigations have revealed that Bcl-2 overexpression may serve as a protective mechanism for keratinocytes against apoptosis induction. Keratinocytes are often subdivided into distinct subpopulations, such as basal keratinocytes, which are located proximal to the basal layer. With numerous biomedical research applications utilizing keratinocytes, CD BioSciences provides sophisticated cationic lipid-based Keratinocyte transfection reagent kits, facilitating efficient and robust biomedical research related to keratinocytes.
